These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18533763)

  • 1. Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
    Findling RL
    J Clin Psychiatry; 2008; 69 Suppl 4():9-14. PubMed ID: 18533763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics for the treatment of disruptive behavior.
    Lohr WD; Honaker J
    Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
    McDougle CJ; Stigler KA; Erickson CA; Posey DJ
    J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of atypical antipsychotics in pediatric bipolar disorder.
    Chang KD
    J Clin Psychiatry; 2008; 69 Suppl 4():4-8. PubMed ID: 18533762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ
    Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
    Correll CU; Manu P; Olshanskiy V; Napolitano B; Kane JM; Malhotra AK
    JAMA; 2009 Oct; 302(16):1765-73. PubMed ID: 19861668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-generation antipsychotics cause weight gain in youths.
    Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations.
    McKinney C; Renk K
    Clin Psychol Rev; 2011 Apr; 31(3):465-71. PubMed ID: 21130552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive somnolence from aripiprazole in a child.
    Davenport JD; McCarthy MW; Buck ML
    Pharmacotherapy; 2004 Apr; 24(4):522-5. PubMed ID: 15098808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents.
    Martínez-Ortega JM; Diaz-Atienza F; Gutiérrez-Rojas L; Jurado D; Gurpegui M
    Eur Child Adolesc Psychiatry; 2011 Dec; 20(11-12):597-8. PubMed ID: 21927910
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L
    Postgrad Med; 2010 Jul; 122(4):39-48. PubMed ID: 20675970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.
    Wang PS; Schneeweiss S; Setoguchi S; Patrick A; Avorn J; Mogun H; Choudhry NK; Brookhart MA
    J Clin Psychopharmacol; 2007 Dec; 27(6):707-10. PubMed ID: 18004143
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
    Dubois D
    Curr Opin Pediatr; 2005 Apr; 17(2):227-33. PubMed ID: 15800418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care.
    Kolotkin RL; Corey-Lisle PK; Crosby RD; Kan HJ; McQuade RD
    Eur Psychiatry; 2008 Dec; 23(8):561-6. PubMed ID: 18374544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
    Findling RL; McNamara NK
    J Clin Psychiatry; 2004; 65 Suppl 6():30-44. PubMed ID: 15104524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.